Wright Medical Group (WMGI) Cash Flow Statement

Click line-items for a historical chart and %

Net income	-94.06M
Depreciation	10.7M
Stock-based compensation expense	5.68M
Amortization of intangible assets
Amortization of deferred financing costs
Deferred income taxes	2K
Write off of deferred financing costs
Excess tax benefit from stock-based compensation arrangements
Non-cash restructuring charges
Other	2.3M
Accounts receivable	4.69M
Inventories	-22.1M
Prepaid expenses and other current assets	1.91M
Accounts payable	6.61M
Accrued expenses and other liabilities	20.02M
Net cash provided by operating activities	-51M
Capital expenditures	-25.75M
Acquisitions of businesses	0
Purchase of intangible assets	-82K
Sales and maturities of available-for-sale marketable securities	2.57M
Investment in available-for-sale marketable securities
Proceeds from sale of assets
Net cash used in investing activities	-23.27M
Issuance of common stock	1.87M
Financing under factoring agreement, net
Payments of long term borrowings
Redemption of convertible senior notes	-240M
Proceeds from term loan borrowings
Payments of deferred financing costs
Excess tax benefit from stock-based compensation arrangements
Net cash used in financing activities	276.26M
Effect of exchange rates on cash and cash equivalents	-1.45M
Net increase in cash and cash equivalents	200.54M
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period

Entities mentioned with WMGI

View All Entities